Latest Breaking News On - Interchange capital partners - Page 4 : comparemela.com

Recursion Pharmaceuticals (NASDAQ:RXRX) Receives Buy Rating from Needham & Company LLC

Recursion Pharmaceuticals (NASDAQ:RXRX) Receives Buy Rating from Needham & Company LLC
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Blake borgesonChristopher gibsonRecursion pharmaceuticalsVanguard group incAnalyst recommendations for recursion pharmaceuticalsNeedham companyInterchange capital partnersKingsview wealth managementSecurities exchange commissionRecursion pharmaceuticals stock downRecursion pharmaceuticals incNews ratings for recursion pharmaceuticals dailyRecursion pharmaceuticals company profileInstitutional investors weigh in on recursion pharmaceuticalsGet free reportPharmaceuticals stock down

Recursion Pharmaceuticals (NASDAQ:RXRX) Receives Buy Rating from Needham & Company LLC

Recursion Pharmaceuticals (NASDAQ:RXRX) Receives Buy Rating from Needham & Company LLC
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Tina marriottMichael secoraAnalyst recommendations for recursion pharmaceuticalsRecursion pharmaceuticals price performanceInstitutional investors weigh in on recursion pharmaceuticalsRecursion pharmaceuticalsNeedham companyRecursion pharmaceuticals incVanguard group incNews ratings for recursion pharmaceuticals dailyKingsview wealth managementSecurities exchange commissionInterchange capital partnersFree reportGet free reportExchange commission

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Up Following Earnings Beat

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Up Following Earnings Beat
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Tina marriottChristopher gibsonKingsview wealth managementRecursion pharmaceuticals trading downSwiss national bankRecursion pharmaceuticalsNeedham companyHedge funds weigh in on recursion pharmaceuticalsRussell investments group ltdRecursion pharmaceuticals incNews ratings for recursion pharmaceuticals dailySecurities exchange commissionProshare advisorsInterchange capital partnersGet free reportExchange commission

CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 3 1% Following Weak Earnings

CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 3 1% Following Weak Earnings
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Jamesr kasingerRobertw bairdSamarth kulkarniSecurities exchange commissionMorgan stanleyReynders mcveigh capital managementTherapeutics company profileInterchange capital partnersCantor fitzgeraldBlair william coProshare advisorsGet free reportGeneral counsel jamesExchange commissionCapital partnersShare advisors

Unity Software (NYSE:U) Earns Market Perform Rating from JMP Securities

Unity Software (NYSE:U) Earns Market Perform Rating from JMP Securities
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United kingdomSouth koreaUnited statesPiper sandlerU stifel nicolausUnity software incMitsubishi ufjInterchange capital partnersRussell investments group ltdUnity softwareAnalyst recommendations for unity softwareHedge funds weigh in on unity softwareNeedham companyUnity software price performanceAsset management coBlair william co